{"id":282666,"date":"2026-10-01T10:04:41","date_gmt":"2026-10-01T04:34:41","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=282666"},"modified":"2026-10-22T10:13:23","modified_gmt":"2026-10-22T04:43:23","slug":"why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/","title":{"rendered":"Alkem Laboratories Ltd. (ALKEM) 52 Week Low Streak Continues"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/alkem\/alkem-laboratories-ltd-share-price-today\">Alkem Laboratories Ltd. (ALKEM)<\/a> share price is trading within 2% of its 52-week low today and stood at Rs 4,929.1, down 0.73% from the previous close. Market cap was Rs 59,722.72 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;\">Alkem Laboratories Ltd. (ALKEM) has now traded within 2% of its 52-week low for its second straight session, with the stock down 1.32% across that stretch. At 9:52 AM IST, the share price was trading at Rs 4,929.10 after touching a low of Rs 4,879.85 during the day. The latest Univest data confirms the repeated-low pattern, but it does not establish a company-specific cause for the continued weakness.<\/p>\n<p>The previous close stood at Rs 4,965.15, while the stock opened at Rs 4,996.90 and touched the same level as its day high before easing lower. The company\u2019s market capitalisation stood at Rs 59,722.72 crore. For a reader, the key point is not just the day\u2019s slip, but the fact that the stock has remained near its 52-week trough across back-to-back sessions rather than in a one-off move.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/#Alkem_Laboratories_Ltd_ALKEM_52_Week_Low_Streak_Consecutive_Low_Analysis\" title=\"Alkem Laboratories Ltd. (ALKEM) 52 Week Low Streak: Consecutive Low Analysis\">Alkem Laboratories Ltd. (ALKEM) 52 Week Low Streak: Consecutive Low Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/#Why_Alkem_Laboratories_Ltd_ALKEM_May_Be_Moving_Today\" title=\"Why Alkem Laboratories Ltd. (ALKEM) May Be Moving Today\">Why Alkem Laboratories Ltd. (ALKEM) May Be Moving Today<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/#What_the_Repeated_52-Week_Lows_Show\" title=\"What the Repeated 52-Week Lows Show\">What the Repeated 52-Week Lows Show<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/#Alkem_Laboratories_Ltd_ALKEM_Fundamental_Analysis\" title=\"Alkem Laboratories Ltd. (ALKEM) Fundamental Analysis\">Alkem Laboratories Ltd. (ALKEM) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/#Why_Investors_Are_Watching\" title=\"Why Investors Are Watching\">Why Investors Are Watching<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/#About_the_Company\" title=\"About the Company\">About the Company<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/#What_does_the_Alkem_Laboratories_Ltd_ALKEM_52_Week_Low_Streak_mean\" title=\"What does the Alkem Laboratories Ltd. (ALKEM) 52 Week Low Streak mean?\">What does the Alkem Laboratories Ltd. (ALKEM) 52 Week Low Streak mean?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/#How_many_sessions_has_Alkem_Laboratories_Ltd_ALKEM_stayed_near_its_low\" title=\"How many sessions has Alkem Laboratories Ltd. (ALKEM) stayed near its low?\">How many sessions has Alkem Laboratories Ltd. (ALKEM) stayed near its low?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/#Did_the_data_confirm_a_company-specific_reason_for_the_decline\" title=\"Did the data confirm a company-specific reason for the decline?\">Did the data confirm a company-specific reason for the decline?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/#How_does_Alkem_Laboratories_Ltd_ALKEM_look_on_valuation\" title=\"How does Alkem Laboratories Ltd. (ALKEM) look on valuation?\">How does Alkem Laboratories Ltd. (ALKEM) look on valuation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/#How_do_Alkems_profitability_ratios_compare_with_peers\" title=\"How do Alkem\u2019s profitability ratios compare with peers?\">How do Alkem\u2019s profitability ratios compare with peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/#What_recent_news_could_matter_for_Alkem_Laboratories_Ltd_ALKEM_stock\" title=\"What recent news could matter for Alkem Laboratories Ltd. (ALKEM) stock?\">What recent news could matter for Alkem Laboratories Ltd. (ALKEM) stock?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/#What_should_investors_monitor_next_in_Alkem_Laboratories_Ltd_ALKEM_share_price_today\" title=\"What should investors monitor next in Alkem Laboratories Ltd. (ALKEM) share price today?\">What should investors monitor next in Alkem Laboratories Ltd. (ALKEM) share price today?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/#Track_Alkem_Laboratories_Ltd_ALKEM_Share_Price_on_Univest\" title=\"Track Alkem Laboratories Ltd. (ALKEM) Share Price on Univest\">Track Alkem Laboratories Ltd. (ALKEM) Share Price on Univest<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Alkem_Laboratories_Ltd_ALKEM_52_Week_Low_Streak_Consecutive_Low_Analysis\"><\/span><strong>Alkem Laboratories Ltd. (ALKEM) 52 Week Low Streak: Consecutive Low Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4,929.1<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4,965.15<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs -36.05 (-0.73%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4,996.9<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4,996.9<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4,879.85<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 59,722.72 crore<\/td>\n<\/tr>\n<\/table>\n<p>Alkem Laboratories Ltd. (ALKEM) traded at Rs 4,929.1 versus the previous close of Rs 4,965.15, a fall of 0.73%. The stock opened at Rs 4,996.9, reached a high of Rs 4,996.9, touched a low of Rs 4,879.85.<\/p>\n<p>Alkem Laboratories Ltd. (ALKEM) share price today is trading below the previous close, with the stock at Rs 4,929.10 versus Rs 4,965.15 earlier. That reflects a fall of Rs 36.05, or 0.73%, in the ongoing session. The intraday range has been Rs 4,996.90 on the high side and Rs 4,879.85 on the low side, which places the current price in the lower half of the day\u2019s band. The stock had opened exactly at Rs 4,996.90, then moved lower, showing that the day\u2019s early level did not hold.<\/p>\n<p>The broader market-capitalisation read is Rs 59,722.72 crore, which keeps Alkem Laboratories Ltd. (ALKEM) among the larger listed names in the healthcare space. The present move should be read in the context of the repeated near 52-week low pattern rather than as a single-session event. That matters because the stock has stayed close to its yearly low for two sessions in a row, making the <strong>Alkem Laboratories Ltd. (ALKEM) 52 Week Low Streak<\/strong> the central market signal for readers tracking the share price, the stock performance and the current weakness in the counter.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Alkem_Laboratories_Ltd_ALKEM_May_Be_Moving_Today\"><\/span><strong>Why Alkem Laboratories Ltd. (ALKEM) May Be Moving Today<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>According to recent news reports, Alkem Laboratories\u2019 audit committee has authorised Grant Thornton to conduct a forensic audit over alleged fund misuse by a former employee. That development may be linked to the continued weakness in <strong>Alkem Laboratories Ltd. (ALKEM) share price<\/strong>, as such proceedings can keep governance and disclosure questions in focus. The news does not prove causation, but it coincides with the stock\u2019s second straight near 52-week low reading and could be one factor investors are watching in the current stock news flow.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_the_Repeated_52-Week_Lows_Show\"><\/span><strong>What the Repeated 52-Week Lows Show<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The key message from the <strong>Alkem Laboratories Ltd. (ALKEM) 52 Week Low Streak<\/strong> is that the stock is not merely reacting to one intraday move. It has stayed within 2% of its one-year low for a second straight session, and the cumulative decline across that stretch is 1.32%. That repeated proximity to the yearly low suggests a persistent market preference for marking the stock lower, but the data available here stops short of confirming why that pattern has continued.<\/p>\n<p>For investors tracking <strong>Alkem Laboratories Ltd. (ALKEM) stock analysis<\/strong>, the distinction matters. A one-day dip can be temporary, but a consecutive near-low pattern often becomes part of the broader share price update narrative. In this case, Univest data confirms the price pattern, while the cause remains unconfirmed. That is why the focus keyword for this event is not simply the share price, but the <strong>Alkem Laboratories Ltd. (ALKEM) Consecutive 52 Week Low<\/strong> trend.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Alkem_Laboratories_Ltd_ALKEM_Fundamental_Analysis\"><\/span><strong>Alkem Laboratories Ltd. (ALKEM) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 59,722.72 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.52x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.15x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">18.29%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21.28%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 180.45<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,196.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.07%<\/td>\n<\/tr>\n<\/table>\n<p>Alkem Laboratories Ltd. (ALKEM) fundamental metrics show P\/E 27.52x, P\/B 4.15x, ROE 18.29%, ROCE 21.28%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Alkem Laboratories Ltd. has a market capitalisation of Rs 59,722.72 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 27.52x, P\/B at 4.15x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.29% and ROCE of 21.28%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 180.45, book value per share of Rs 1,196.51, dividend yield of 1.07%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 26.67x, median ROE of 11.23%, median ROCE of 13.17%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.52x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.67x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">38.83x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 616.23x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.15x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.67x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">18.29%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.23%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21.28%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.17%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 59,722.72 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 768.75 crore<\/td>\n<\/tr>\n<\/table>\n<p>Alkem Laboratories Ltd. (ALKEM) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Alkem Laboratories Ltd. (ALKEM) has a P\/E ratio of 27.52x, which is above the benchmark median of 26.67x, a difference of +3.19%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Alkem Laboratories Ltd. (ALKEM) has a ROE of 18.29%, which is above the benchmark median of 11.23%, a difference of +62.87%. Alkem Laboratories Ltd. (ALKEM) has a ROCE of 21.28%, which is above the benchmark median of 13.17%, a difference of +61.58%.<\/p>\n<p>Track stocks falling to yearly lows through the <a href=\"https:\/\/univest.in\/screeners\/52-week-low\">Univest 52-week-low screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/glenmark\/glenmark-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Glenmark Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">GLENMARK<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">62,339.2<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">34.61<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.68<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.1<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">20.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/biocon\/biocon-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Biocon Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BIOCON<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">55,491.09<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">109.73<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1.6<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1.35<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.26<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/abbotindia\/abbott-india-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Abbott India Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ABBOTINDIA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">54,909.79<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.88<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.57<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">34.67<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">46.72<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><strong>Gland Pharma Ltd.<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">GLAND<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">49,952.91<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">42.75<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.54<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.56<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.96<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/ipcalab\/ipca-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Ipca Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">IPCALAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">46,049.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">37.13<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.73<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.88<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.41<\/td>\n<\/tr>\n<\/table>\n<p>Alkem Laboratories Ltd. (ALKEM) has a P\/E ratio of 27.52x compared with the displayed peer median of 37.13x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.29% compares with a peer median of 14.1% across the companies shown in the table. ROCE stood at 21.28% versus the displayed peer median of 19.41%, providing a capital-efficiency comparison. Alkem Laboratories Ltd. (ALKEM) has a market capitalisation of Rs 59,722.72 crore. Among the 5 peers shown, only 1 has a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching\"><\/span><strong>Why Investors Are Watching<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>The stock has traded within 2% of its 52-week low for a second straight session, keeping the near-low pattern in focus.<\/li>\n<li>The cumulative decline across the streak is 1.32%, which is more relevant than the day\u2019s isolated move.<\/li>\n<li>The company\u2019s P\/E, P\/B, ROE and ROCE suggest the decline is not being explained by weak profitability alone.<\/li>\n<li>The audit committee-approved forensic audit is a fresh development that may remain relevant for sentiment and stock news tracking.<\/li>\n<li>Investors may watch whether the share price continues to stay near the one-year low or starts trading away from it in the coming sessions.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_the_Company\"><\/span><strong>About the Company<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Alkem Laboratories Ltd. (ALKEM) is a pharmaceutical company listed on the NSE and BSE, operating in the healthcare sector under the pharmaceuticals &amp; drugs industry. The company\u2019s market capitalisation places it among the larger names in the space, and its financial metrics show a business with healthy returns on capital and equity. The current <strong>Alkem Laboratories Ltd. (ALKEM) share price update<\/strong> is therefore being viewed through both the stock price lens and the company\u2019s fundamental profile.<\/p>\n<p>For readers tracking <strong>Alkem Laboratories Ltd. (ALKEM) stock analysis<\/strong>, the important distinction is that the business metrics supplied here do not align with a distressed balance-sheet profile. At the same time, the stock price has remained near a yearly low for consecutive sessions, and that is what gives the present market update its significance. The current streak is about price behaviour, not a change in the company\u2019s long-term business model.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_does_the_Alkem_Laboratories_Ltd_ALKEM_52_Week_Low_Streak_mean\"><\/span><strong>What does the Alkem Laboratories Ltd. (ALKEM) 52 Week Low Streak mean?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> It means the stock has traded within 2% of its 52-week low for consecutive sessions. In this case, Alkem Laboratories Ltd. (ALKEM) has done so for a second straight session, which keeps the yearly-low pattern in focus.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_many_sessions_has_Alkem_Laboratories_Ltd_ALKEM_stayed_near_its_low\"><\/span><strong>How many sessions has Alkem Laboratories Ltd. (ALKEM) stayed near its low?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As per the latest Univest data, Alkem Laboratories Ltd. (ALKEM) has stayed within 2% of its 52-week low for two consecutive sessions. That is the key streak signal behind the current stock news.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_the_data_confirm_a_company-specific_reason_for_the_decline\"><\/span><strong>Did the data confirm a company-specific reason for the decline?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. The supplied information confirms the repeated near-low pattern, but it does not establish a company-specific cause. The news flow may be relevant, but the cause is not confirmed by the price data alone.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Alkem_Laboratories_Ltd_ALKEM_look_on_valuation\"><\/span><strong>How does Alkem Laboratories Ltd. (ALKEM) look on valuation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock trades at a P\/E of 27.52 and a P\/B of 4.15. On the supplied healthcare benchmark, that is slightly above the industry median P\/E and well above the median P\/B, while profitability remains stronger than the benchmark median.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_do_Alkems_profitability_ratios_compare_with_peers\"><\/span><strong>How do Alkem\u2019s profitability ratios compare with peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Alkem\u2019s ROE of 18.29% and ROCE of 21.28% are above the industry median values in the supplied set. That suggests solid capital efficiency even as the share price remains near its 52-week low.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_recent_news_could_matter_for_Alkem_Laboratories_Ltd_ALKEM_stock\"><\/span><strong>What recent news could matter for Alkem Laboratories Ltd. (ALKEM) stock?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The audit committee\u2019s decision to approve a forensic audit by Grant Thornton over alleged fund misuse by a former employee may be relevant. It does not prove causation, but it is a notable development in the company news flow.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_monitor_next_in_Alkem_Laboratories_Ltd_ALKEM_share_price_today\"><\/span><strong>What should investors monitor next in Alkem Laboratories Ltd. (ALKEM) share price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors may track whether the stock continues to trade near the one-year low or begins moving away from that zone. The next reads on price, company news and the market\u2019s response to the forensic audit will be important.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Alkem_Laboratories_Ltd_ALKEM_Share_Price_on_Univest\"><\/span><strong>Track Alkem Laboratories Ltd. (ALKEM) Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/alkem\/alkem-laboratories-ltd-share-price-today\">Alkem Laboratories Ltd. (ALKEM) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-low\">Univest 52-week-low screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-low lists and related market analysis.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Alkem Laboratories Ltd. Share Price trades near its 52-week low at Rs 4,929.1, marking a 0.73% decline today. Market cap stands at Rs 59,722.72 crore.<\/p>\n","protected":false},"author":38,"featured_media":322398,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-282666","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["322398"],"rank_math_title":["Alkem Laboratories Ltd. (ALKEM) Near 52-Week Low Streak"],"rank_math_description":["Alkem Laboratories Ltd. (ALKEM) 52 Week Low Streak: Alkem Laboratories Ltd. (ALKEM) has traded within 2% of its 52-week low for a second straight session. Read"],"rank_math_focus_keyword":["Alkem Laboratories Ltd. (ALKEM) 52 Week Low Streak"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/alkem-laboratories-ltd-alkem-52-week-low-streak-continues.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/282666","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=282666"}],"version-history":[{"count":3,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/282666\/revisions"}],"predecessor-version":[{"id":322399,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/282666\/revisions\/322399"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/322398"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=282666"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=282666"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=282666"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}